Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 study. [electronic resource]

By: Contributor(s): Producer: 19910927Description: 146 p. digitalISSN:
  • 0268-3369
Subject(s): In: Bone marrow transplantation vol. 7 Suppl 2
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Journal Article; Multicenter Study

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close